Skip to content
StockMarketAgent
Healthcare / Medical - Diagnostics & ResearchUpdated 2026-05-10 22:07 UTC

TYO/6090 stock hub

TYO/6090 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

TYO/6090is not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
3.9B
Tokyo Stock Exchange
Market data

Live price

Current market quote for this ticker.

Current price
TYO/6090
In the news

Latest news · TYO/6090

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a
P25 12.7P50 15.8P75 21.7
Trailing P/E19.2
P25 11.7P50 15.2P75 22.3
ROE11
P25 -1.6P50 7.1P75 11.9
ROIC30.5
P25 -0.6P50 6.2P75 14.3
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All TYO/6090 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
232
Groups with data
11
Currency
JPY
Showing 232 of 232 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

20
MetricValue
Country
Japan
Country code
JP
Employees
62
Employees Change
4%
Employees Change Percent
6.9
Enterprise value
JPY 2.8B
Exchange
Tokyo Stock Exchange
Financial currency
JPY
First seen
2026-05-10
Industry
Medical - Diagnostics & Research
Isin
JP3794530000
Last refreshed
2026-05-10
Market cap
JPY 3.9B
Price
JPY 688
Price currency
JPY
Rev Per Employee
23,064,516.13x
Sector
Healthcare
Sic
3845
Symbol
tyo/6090
Website
https://www.humanmetabolome.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

12
MetricValue
Earnings Yield
5.32%
EV Earnings
13.44x
EV/EBIT
14.42x
EV/EBITDA
9.14x
EV/FCF
106.49x
EV/Sales
1.94x
FCF yield
0.67%
P/B ratio
2.14x
P/E ratio
19.19x
P/S ratio
2.71x
PE Ratio3 Y
15.97x
PE Ratio5 Y
24.86x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

27
MetricValue
EBIT Margin
13.43%
EBITDA Margin
21.19%
FCF margin
1.82%
Gross margin
60.49%
Gross Profit
JPY 865M
Gross Profit Growth
-5.15%
Gross Profit Growth Q
7.39%
Gross Profit Growth3 Y
0.19%
Gross Profit Growth5 Y
-1.12%
Net Income
JPY 206M
Net Income Growth
-22.26%
Net Income Growth Q
9.38%
Net Income Growth Quarters
1%
Net Income Growth Years
1%
Net Income Growth3 Y
-7.35%
Net Income Growth5 Y
26.34%
Pretax Margin
14.97%
Profit Margin
14.41%
Profit Per Employee
JPY 3.3M
Profitable Years
5
ROA
5.24
Roa5y
5.2
ROCE
10.52
ROE
11.04
Roe5y
13.61
ROIC
30.52
Roic5y
67.03

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

23
MetricValue
Cagr10y
-1.73%
Cagr1y
4.45%
Cagr3y
0.89%
Cagr5y
-4.09%
EPS Growth
-19.96
EPS Growth Q
14.62
EPS Growth Quarters
1
EPS Growth Years
1
EPS Growth3 Y
-6.5
EPS Growth5 Y
26.93
FCF Growth
-91.9%
FCF Growth3 Y
-53.46%
FCF Growth5 Y
0%
OCF Growth
-76.42%
OCF Growth10 Y
4.65%
OCF Growth3 Y
-28.37%
OCF Growth5 Y
8.87%
Revenue Growth
2.36x
Revenue Growth Q
13.9x
Revenue Growth Quarters
1x
Revenue Growth Years
5x
Revenue Growth3 Y
3.23x
Revenue Growth5 Y
3.55x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

23
MetricValue
Asset Turnover
JPY 0.62
Assets
JPY 2.1B
Cash
JPY 1.2B
Current Assets
JPY 1.6B
Current Liabilities
JPY 312M
Debt
JPY 105M
Debt EBITDA
JPY 0.35
Debt Equity
JPY 0.06
Debt FCF
JPY 4.04
Equity
JPY 1.8B
Interest Coverage
96
Liabilities
JPY 329M
Long Term Assets
JPY 491M
Long Term Liabilities
JPY 17M
Net Cash
JPY 1.1B
Net Cash By Market Cap
JPY 28.49
Net Cash Growth
-20.01%
Net Debt EBITDA
JPY -3.64
Net Debt Equity
JPY -0.61
Net Debt FCF
JPY -42.42
Tangible Book Value
JPY 1.8B
Tangible Book Value Per Share
JPY 318
WACC
3.83

Liquidity

Current-asset coverage and working-capital efficiency metrics.

6
MetricValue
Current ratio
5.28
Inventory Turnover
10.37
Net Working Capital
JPY 228M
Quick ratio
5.03
Working Capital
JPY 1.3B
Working Capital Turnover
JPY 1.04

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

10
MetricValue
Buyback Yield
2.88%
Dividend Growth
20%
Dividend Growth Years
0%
Dividend per share
JPY 18
Dividend Years
4
Dividend Yield
2.62%
Ex Div Date
2026-06-29
Last Dividend
JPY 18
Payout Frequency
Annual
Payout Ratio
40.78%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

38
MetricValue
10Y total return
-16.05%
1Y total return
4.45%
200-day SMA
708.6
3Y total return
2.68%
50-day SMA
702.5
50-day SMA vs 200-day SMA
50under200
5Y total return
-18.86%
All Time High
5,920
All Time High Change
-88.38%
All Time High Date
2014-01-06
All Time Low
453
All Time Low Change
51.88%
All Time Low Date
2020-03-13
ATR
9.81
Beta
-0.07
Beta1y
-0.18
Beta2y
0.23
Ch YTD
4.24
High
696
High52
869
High52 Date
2025-06-05
High52ch
-20.83%
Low
686
Low52
631
Low52 Date
2025-12-15
Low52ch
9.03%
Ma50ch
-2.06%
Price vs 200-day SMA
-2.91%
RSI
41.9
RSI Monthly
48.96
RSI Weekly
46.25
Sharpe ratio
0.02x
Sortino ratio
0.23
Total Return
5.5%
Tr YTD
4.24
Tr1m
-1.43%
Tr1w
-0.29%
Tr3m
-0.72%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

6
MetricValue
Operating Income
JPY 192M
Operating Income Growth
-24.41
Operating Income Growth Q
25.45
Operating Income Growth3 Y
-1.19
Operating Income Growth5 Y
12.2
Operating margin
13.43

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

7
MetricValue
Float
4,399,419%
Net Borrowing
-100,000,000
Shares Insiders
15.3%
Shares Institutions
10.87%
Shares Out
5,627,579
Shares Qo Q
-0.58%
Shares Yo Y
-2.88%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

60
MetricValue
Adjusted FCF
JPY 26M
Average Volume
4,700x
Bv Per Share
321.3
CAPEX
JPY -78M
Ch10y
-20.55
Ch1m
-1.43
Ch1w
-0.29
Ch1y
2.53
Ch3m
-0.72
Ch3y
-2.82
Ch5y
-23.21
Ch6m
-1.01
Change
0.29%
Change From Open
0.29
Close
686
Days Gap
0
Depreciation Amortization
111,000,000
Dollar Volume
3,508,800
Earnings Date
2026-08-07
EBIT
JPY 192M
EBITDA
JPY 303M
EPS
JPY 35.85
F Score
5
FCF
JPY 26M
FCF EV Yield
0.94x
FCF Per Share
JPY 4.62
Financing CF
-408,000,000
Fiscal Year End
June
Founded
2,003
Graham Number
509.07923
Graham Upside
-26.01
Income Tax
JPY 8M
Investing CF
-84,000,000
Is Primary Listing
1
Last Earnings Date
2026-02-12
Last Report Date
2025-12-31
Lynch Fair Value
JPY 896
Lynch Upside
30.28
Ma150
693.6
Ma150ch
-0.81%
Ma20
699.2
Ma20ch
-1.59%
Net CF
-388,000,000
Next Earnings Date
2026-08-07
Open
686
P FCF Ratio
148.9
P OCF Ratio
37.23
Payment Date
2026-09-04
Position In Range
20
Ppne
274,000,000
Price Date
2026-05-08
Price EBITDA
JPY 12.78
Ptbv Ratio
2.16
Relative Volume
1.07x
Revenue
1,430,000,000x
Tax By Revenue
0.56x
Tax Rate
3.74%
Tr6m
-1.01%
Volume
5,100
Z Score
9.57
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

TYO/6090 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield
+2.6%
$18.0 annual per share
Payout ratio
+40.8%
Share of earnings returned as dividends. Below 60% is generally sustainable.
5Y dividend CAGR
n/a
0 consecutive years of growth
Total shareholder yield
+5.5%
Next ex-dividend date: 2026-06-29
Performance

TYO/6090 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
+4.5%
S&P 500 1Y: n/a
3Y total return
+2.7%
S&P 500 3Y: n/a
5Y total return
-18.9%
S&P 500 5Y: n/a
10Y total return
-16.1%
S&P 500 10Y: n/a
Ownership

Who owns TYO/6090?

Insider, institutional, and short-interest positioning.

Institutional ownership
+10.9%
Share of float held by funds and institutions
Insider ownership
+15.3%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
Float sold short by bearish positioning
Y/Y dilution
-2.9%
Negative means the company is buying back shares.
Technical

TYO/6090 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
41.9
Neutral momentum band
Price vs 200-day MA
-2.9%
50/200-day relationship not available
Beta (5Y)
-0.07
Less volatile than the market
Sharpe ratio
0.02
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About TYO/6090

Hub-level FAQ points readers to the deeper analysis pages.

What is the current tyo/6090 stock rating?

tyo/6090 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full tyo/6090 analysis?

The full report lives at /stocks/tyo/6090/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for tyo/6090?

The latest report frames tyo/6090 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the tyo/6090 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.